$FXCM Recent Headlines FXCM to sell 'non-core assets'

New Post Public Reply Private Reply Replies (0) Message Board

Jan 27, 2015 at 1:15 PM

$FXCM Recent Headlines

FXCM to sell 'non-core assets' to pay back Leucadia bailout 6:35 p.m. Jan. 23, 2015 - Tom Bemis
FXCM to consider sale of noncore assets to help repay rescue loan 4:20 p.m. Jan. 23, 2015 - Jenny Strasburg
FXCM's stock down 25%, but pares earlier loss of as much as 35% 3:57 p.m. Jan. 23, 2015 - Tomi Kilgore
FXCM raising gold, currency margin requirements 2:21 p.m. Jan. 21, 2015 - Wallace Witkowski
What happens if the ECB pulls a Swiss-style surprise 7:30 a.m. Jan. 21, 2015 - Barbara Kollmeyer
Netflix surges after earnings, subscriber growth beats 6:33 p.m. Jan. 20, 2015 - Victor Reklaitis
FXCM's stock plunging 89% in premarket trade 8:17 a.m. Jan. 20, 2015 - Tomi Kilgore
FXCM rescue package includes rising interest rate 8:06 a.m. Jan. 20, 2015 - Wall Street Journal staff
Currency brokers’ reassurances about Swiss exposure are a red flag for the rest of us 10:09 a.m. Jan. 17, 2015 - Tomi Kilgore
Swiss fallout drives euro to 11-year low against dollar 6:19 p.m. Jan. 16, 2015 - Sara Sjolin
U.S. stocks rebound from Swiss shock, but still record weekly loss 4:45 p.m. Jan. 16, 2015 - Barbara Kollmeyer
FXCM's stock down 68% in after-hours trade after halt lifted 4:28 p.m. Jan. 16, 2015 - Tomi Kilgore
Leucadia to provide FXCM with $300 million loan 4:10 p.m. Jan. 16, 2015 - Tomi Kilgore
Leucadia loan will allow FXCM to meet regulatory-capital requirements 4:00 p.m. Jan. 16, 2015 - Tomi Kilgore
Leucadia to provide $300 mln to FXCM as part of a rescue package 3:59 p.m. Jan. 16, 2015 - Tomi Kilgore
Intel, Goldman Sachs drop, while Netflix gains 3:29 p.m. Jan. 16, 2015 - Sue Chang
Deutsche Bank, Citi among banks whacked by losses after Swiss shock 2:29 p.m. Jan. 16, 2015 - David Enrich
10 biggest financial-market events this week 1:08 p.m. Jan. 16, 2015 - Philip van Doorn
Leucadia shares halted, pending news 12:48 p.m. Jan. 16, 2015 - Ciara Linnane
Jefferies may rescue battered FXCM, reports say 11:18 a.m. Jan. 16, 2015 - Ciara Linnane

Insider Trading Alert - CLFD, FXCM And CRM Traded By Insiders 11:17 a.m. Today - TheStreet.com
The Decline Of FXCM Is An Opportunity For GAIN Capital 8:50 a.m. Today - Seeking Alpha
Forex Capital Markets (FXCM) Fights Back - Video Blog 4:19 p.m. Jan. 26, 2015 - Zacks.com
If Your Broker Did Not Lose Money In The CHF Debacle You Should Be Afraid 2:28 p.m. Jan. 26, 2015 - Seeking Alpha
FXCM (FXCM) Marked As A Dead Cat Bounce Stock 9:45 a.m. Jan. 26, 2015 - TheStreet.com
Citi Ignores FXCM Buyout Rumors, Says Challenges Ahead 8:16 a.m. Jan. 26, 2015 - benzinga.com
FXCM Considers Sale Of Non-Core Assets: How Does This Impact Its Valuation? 4:51 a.m. Jan. 26, 2015 - Seeking Alpha
FXCM Reports An Account Loss Of 3%, Leucadia Tightens Its Grip On The Company 12:54 a.m. Jan. 26, 2015 - Seeking Alpha
Swiss Franc’s Leap Lifts Some FX Brokers 5:10 p.m. Jan. 25, 2015 - The Wall Street Journal Interactive Edition
FXCM Tries To Slip Bad News Past Investors 1:41 a.m. Jan. 24, 2015 - Seeking Alpha
Leucadia Puts FXCM On Life Support - Some Very Simple Numbers, As The Price Discovery Process Progresses... Slowly 11:06 p.m. Jan. 23, 2015 - Seeking Alpha
FXCM to Consider Sale of Noncore Assets 8:18 p.m. Jan. 23, 2015 - The Wall Street Journal Interactive Edition
FXCM: This Equity Is Nearly Worthless 7:28 p.m. Jan. 23, 2015 - Seeking Alpha
Regulator Boosts Requirements on Forex Trades 6:34 p.m. Jan. 23, 2015 - The Wall Street Journal Interactive Edition
Citi Sees 75% Downside On FXCM Shares 12:02 p.m. Jan. 23, 2015 - benzinga.com
One Reason FXCM Stock Is Plunging Again Today 10:16 a.m. Jan. 23, 2015 - TheStreet.com
Today's Perilous Reversal Stock: FXCM (FXCM) 9:47 a.m. Jan. 23, 2015 - TheStreet.com
Stocks Rally; S&P 500 Hits 2015 High 4:45 p.m. Jan. 22, 2015 - The Wall Street Journal Interactive Edition
1 Way To Trade FXCM 3:20 p.m. Jan. 22, 2015 - benzinga.com
The Bearish Case For FXCM: Will It Collect On Debit Balances Outstanding And What Are The Consequences? 3:14 p.m. Jan. 22, 2015 - Seeking Alpha

SHAREHOLDER ALERT: The Wagner Firm Announces Investigation of the Board of Directors of FXCM, Inc. 11:00 a.m. Today - BusinessWire - BZX
Insider Trading Alerts for FXCM, Achillion Pharmaceuticals, Ariad Pharmaceuticals, Kinder Morgan, Twitter, and Yahoo 8:45 a.m. Today - PR Newswire - PRF
Earnings Forecast Research for Apple, Alibaba, FXCM, Gilead Sciences, Freeport-McMoRan, and Bank of America 8:45 a.m. Jan. 26, 2015 - PR Newswire - PRF
FXCM SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of FXCM Inc. 11:01 p.m. Jan. 23, 2015 - BusinessWire - BZX
FXCM Provides Business Update 6:20 p.m. Jan. 23, 2015 - GlobeNewswire
FXCM SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of FXCM Inc. 10:34 a.m. Jan. 23, 2015 - PR Newswire - PRF
Insider Trading Research for Delta Air Lines, Ariad Pharmaceuticals, Alcoa, Avon, FXCM, and Apple 8:45 a.m. Jan. 23, 2015 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of FXCM Inc. Stockholders 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
SHAREHOLDER ALERT: Investigation on Behalf of Investors of FXCM, Inc. Announced by Law Offices of Howard G. Smith 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
Earnings Forecast Research for FXCM, Advanced Micro Devices, BlackBerry, Alibaba, Netflix, and Sirius XM 8:45 a.m. Jan. 22, 2015 - PR Newswire - PRF
Harwood Feffer LLP Announces Investigation of FXCM Inc. 8:00 p.m. Jan. 21, 2015 - PR Newswire - PRF
FXCM SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of FXCM Inc. 3:15 p.m. Jan. 21, 2015 - BusinessWire - BZX
FXCM Revises FX and Gold Margin Requirements 2:00 p.m. Jan. 21, 2015 - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FXCM, Inc. - FXCM 1:58 p.m. Jan. 21, 2015 - PR Newswire - PRF
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against FXCM Inc. 12:59 p.m. Jan. 21, 2015 - BusinessWire - BZX
FXCM SHAREHOLDER ALERT: National Securities Law Firm Announces Investigation of FXCM Inc. Encourages Investors with Losses in Excess of $1 Million to Contact Law Firm for More Information. 10:07 a.m. Jan. 21, 2015 - PR Newswire - PRF
Insider Trading Buzz for Alcoa, Southwestern Energy, Celgene, Micron, FXCM, and Twitter 8:45 a.m. Jan. 21, 2015 - PR Newswire - PRF
FXCM Provides Further Details on Financing With Leucadia National Corporation 9:25 p.m. Jan. 19, 2015 - GlobeNewswire
Leucadia National Corporation and FXCM Announce $300 Million Financing to Permit FXCM to Continue Normal Operations 3:55 p.m. Jan. 16, 2015 - BusinessWire - BZX
FXCM Comments on Swiss Franc Movement 8:04 p.m. Jan. 15, 2015 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...